Transcatheter Valve Therapies Part I
经导管瓣膜治疗第一部分

1:30 PM-5:00 PM Thursday, March 30, 2017

2017年03月30日 星期四   1:30 PM-5:00 PM

Room 311A, Level 3

三层311A会议室

  Session I: TAVR 2017 - Updates, Insights and Controversies I
第一场：经导管主动脉瓣置换2017 - 进展、见解及争议（一）
Moderator 主持人 Martin B. Leon, Wei Wang 王巍
Discussant 讨论者 Davide Capodanno, Eberhard Grube, Hasan Jilaihawi, Nicolo Piazza, Ron Waksman
  Current and Future Clinical Indications
经导管主动脉瓣置换临床治疗现状和未来

1:30 PM-

Main Lessons from Previous TAVR Clinical Trials
既往经导管主动脉瓣置换临床研究启示		 Nicolo Piazza

1:40 PM-

A Preview and Rationale for Ongoing and Future TAVR Clinical Trials
经导管主动脉瓣置换临床研究预览		 Davide Capodanno

1:50 PM-

Discussion
讨论

1:55 PM-

New Clinical Indications 1: Valve-in-Valve for Bioprosthetic Valve Failure
最新临床拓展1：生物瓣后经导管主动脉瓣置换		 Ron Waksman

2:05 PM-

New Clinical Indications 2: Bicuspid Aortic Valve Disease
最新临床拓展2：二叶式主动脉瓣疾患		 Hasan Jilaihawi

2:15 PM-

New Clinical Indications 3: The Case for Treating Severe Asymptomatic AS (EARLY TAVR)
最新临床拓展3：无症状重度主动脉瓣狭窄患者的经导管主动脉瓣置换（早期TAVR）		 Martin B. Leon

2:25 PM-

New Clinical Indications 4: The Case for Treating Moderate AS and Heart Failure (TAVR UNLOAD)
最新临床拓展4：中度主动脉瓣狭窄合并心衰患者的经导管主动脉瓣置换		 Martin B. Leon

2:35 PM-

Discussion
讨论

2:40 PM-

Featured Lecture: TAVR in Lower Risk Patients
特色讲座：低危外科风险患者的经导管主动脉瓣置换		 Eberhard Grube

2:55 PM-

Discussion
讨论

3:00 PM-

Transcatheter Pulmonary Valve Implantation: From Melody to PT-Valve
经导管肺动脉瓣植入术：从Melody到PT瓣膜		 John P. Cheatham

3:15 PM-

Break
休息
  Session II: TAVR 2017 - Updates, Insights and Controversies II
第二场：经导管主动脉瓣置换2017 - 进展、见解及争议（二）
Moderator 主持人 Eberhard Grube, Nicolo Piazza, Mao Chen 陈茂
Discussant 讨论者 Andreas Baumbach, David Hildick-Smith, Ran Kornowski, Jan Kovac, Raj Makkar

3:30 PM-

Controversy #1: Stroke Concerns after TAVR and the Need for Cerebral Embolic Protection
争议1：经导管主动脉瓣置换神经保护与脑卒中		 Andreas Baumbach

3:40 PM-

Discussion
讨论

3:43 PM-

Controversy #2: Para-valvular Leak after TAVR - Incidence, Diagnosis and Management Algorithms
争议2：经导管主动脉瓣置换术后瓣周漏 - 发生率、评估以及综合管理		 David Hildick-Smith

3:53 PM-

Discussion
讨论

3:56 PM-

Controversy #3: The Importance of Valve Leaflet Thickening and Thrombosis after TAVR
争议3：经导管主动脉瓣置换术后瓣叶增厚以及血栓对预后的影响		 Raj Makkar

4:06 PM-

Discussion
讨论

4:09 PM-

Controversy #4: TAVR Access Site Alternatives - When Trans-Femoral Isn’t an Option
争议4：经导管主动脉瓣置换的其它入路（股动脉禁忌时）		 Raj Makkar

4:19 PM-

Discussion
讨论

4:22 PM-

Controversy #5: The Preferred “Minimalist” Strategy for TAVR - Advantages and Limitations
争议5：经导管主动脉瓣置换的简化策略 - 优势以及缺陷		 Eberhard Grube

4:32 PM-

Discussion
讨论

4:35 PM-

Controversy #6: Reflections on Bioprosthetic Valve Durability - Current Data and Clinical Implications
争议6：经导管主动脉瓣置换生物瓣的耐久性 - 目前数据以及临床启示		 Martin B. Leon

4:45 PM-

Discussion
讨论

4:48 PM-

Featured Lecture: The Essential Role of CT Imaging in TAVR - Present Status and Future Directions
特色讲座：CT在经导管主动脉瓣置换的作用 - 现状与未来		 Hasan Jilaihawi

5:00 PM-

Adjourn
休会